As 60% of the BRCA1 mRNA-high BC patients harbored wild-type p53 in the tumors (data not shown), this mechanism could contribute to the worse overall survival observed in BC patients expressing high levels of BRCA1 mRNA. This evidence concerns the gene BRCA1 and breast cancer.